Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1320
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02770014 | Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer | ||
| NCT01786811 | Serious Illness Communication Project | ||
| NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | ||
| NCT00378209 | Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma | ||
| NCT01596218 | Brentuximab Vedotin for Steroid Refractory GvHD | ||
| NCT05057247 | Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC | ||
| NCT00806715 | Iron Overload in Stem Cell Transplant Recipients | ||
| NCT02438358 | Feasibility Study of Intraoperative Imaging in Breast Cancer | ||
| NCT06677190 | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin | ||
| NCT07465276 | Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC | ||
| NCT00801320 | Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer | ||
| NCT05419479 | Switch Maintenance in Pancreatic | ||
| NCT02268851 | A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL | ||
| NCT05176288 | Avelumab, Palbociclib and Axitinib in Advanced RCC | ||
| NCT00542451 | Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer | ||
| NCT04660422 | Advance Care Planning: Communicating With Outpatients for Vital Informed Decision | ||
| NCT04906096 | Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL | ||
| NCT03846583 | Tucatinib + Abemaciclib + Herceptin for HER2+ MBC | ||
| NCT02919670 | A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma | ||
| NCT00165152 | Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing | ||
| NCT05783609 | Epcoritamab and Rituximab for First-line Follicular Lymphoma | ||
| NCT05565638 | PROFAST Intervention in Precursor Multiple Myeloma | ||
| NCT04482244 | RCT of CBD for Anxiety in Advanced Breast Cancer | ||
| NCT01551693 | STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma | ||
| NCT01112514 | Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract | ||
| NCT07732140 | Listen Aphasia Pilot Study | ||
| NCT04947917 | Axillary Lymph Node Tattoo Marking Study | ||
| NCT03414658 | The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer | ||
| NCT01534078 | Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma | ||
| NCT02450708 | Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes | ||
| NCT04685915 | Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL | ||
| NCT04040725 | Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression | ||
| NCT06475235 | Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL | ||
| NCT02362997 | Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL | ||
| NCT07147023 | Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication | ||
| NCT00928018 | Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma | ||
| NCT05706766 | Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | ||
| NCT00165360 | Prolonged Daily Temozolomide for Low-Grade Glioma | ||
| NCT01065662 | AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | ||
| NCT03351803 | BRCA Founder OutReach (BFOR) Study | ||
| NCT06644183 | Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) | ||
| NCT06709495 | Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas | ||
| NCT00004081 | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | ||
| NCT03557372 | Mathematical Model-Adapted Radiation In Glioblastoma | ||
| NCT03417739 | A Phase II Study of BVD-523 in Metastatic Uveal Melanoma | ||
| NCT06654466 | Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer | ||
| NCT00675831 | Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies | ||
| NCT06945120 | ACT Lung Health Intervention: Phase Two | ||
| NCT07412041 | Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study | ||
| NCT06758102 | Dance Study for Post-surgical Pain in Breast Cancer Survivors |
